ELV logo

Elevance Health (ELV)

Profile

Full Name

Elevance Health, Inc.

Ticker Symbol

ELV

Exchange

NYSE

Sector

Healthcare

Industry

Healthcare Plans

Country

United States

IPO

October 30, 2001

Indexes

S&P 500

Website

http://www.elevancehealth.com

Employees

104200

Key Details

Price

$432.50

Market Cap

Last Dividend

$1.71

TTM Dividend Yield

1.53%

Annual Revenue

$176.81B(+3.19% YoY)

Annual EPS

$25.68(+1.82% YoY)

PE Ratio

16.89

Next earnings date

Apr 18, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$432.50
ELV price is $432.50

Price All-time High

$562.07
ELV price is currently -23.05% below its historical high of $562.07

Price Today Change

+2.04%
ELV price is up +2.04% today

Price YTD Change

+17.61%
ELV price is up +17.61% since January 1st

Price 1-year Change

-12.73%
ELV price is down -12.73% year-on-year

Price 3-year Change

-13.38%
ELV price is down -13.38% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$98.33B
ELV market capitalization is $98.33 billion

Market Cap 3-year Change

-18.34%
ELV market capitalization is down -18.34% over the past 3 years

Market Cap All-time High

$130.58B
ELV market capitalization is currently -24.70% below its historical high of $130.58 billion

Market Cap Sector Rank

98.26%
ELV market capitalization is higher than 98.26% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-2.23%
ELV shares outstanding is down -2.23% year-on-year

Shares Outstanding 3-Year Change

-5.72%
ELV shares outstanding is down -5.72% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.24
ELV beta is 0.24

200-day SMA

$456.92
ELV price is currently -5.34% below its 200-day simple moving average

50-day SMA

$406.14
ELV price is currently +6.49% above its 50-day simple moving average

RSI

61.92
ELV 14-day relative strength index is 61.92

Volume

0.80
ELV 30-day relative volume is 0.80

ATR

$9.47
ELV average true range is $9.47

10-day Historical Volatility

16.33%
ELV 10-day historical volatility is 16.33%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.71
ELV last dividend was $1.71 per share, with an ex-dividend date of March 10, 2025

Next Dividend

-
ELV next dividend has not yet been announced

Dividend per share

Dividend Per Share

$6.52
ELV annual dividend per share is $6.52

Dividend per share Sector Rank

96.47%
ELV annual dividend per share is higher than 96.47% of companies in Healthcare sector

Dividend per share 1-Year Change

+10.14%
ELV annual dividend per share is up +10.14% year-on-year

Dividend per share 3-Year Change

+44.25%
ELV annual dividend per share is up +44.25% over the past 3 years

Dividend yield

Dividend Yield

1.51%
ELV annual dividend yield is 1.51%

Dividend yield Sector Rank

39.29%
ELV annual dividend yield is higher than 39.29% of companies in Healthcare sector

Other

Payout Ratio

25.22%
ELV annual payout ratio is 25.22%

Dividends Paid

$1.51B
ELV annual dividends paid is $1.51 billion

Free Cash Flow

$4.55B
ELV annual free cash flow is $4.55 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$176.81B
ELV annual revenue is $176.81 billion

Revenue Analysts Estimate

$191.66B
ELV annual revenue is currently -7.75% lower than the consensus analysts' forecast

Revenue 1-year Change

+3.19%
ELV annual revenue is up +3.19% year-on-year

Revenue Sector Rank

99.33%
ELV annual revenue is higher than 99.33% of companies in Healthcare sector

EPS

EPS

$25.68
ELV annual earnings per share is $25.68

EPS Analysts Estimate

$34.53
ELV annual earnings per share is currently -25.62% lower than the consensus analysts' forecast

EPS 1-year Change

+1.82%
ELV annual earnings per share is up +1.82% year-on-year

EPS Sector Rank

99.5%
ELV annual earnings per share is higher than 99.5% of companies in Healthcare sector

Profit

Gross Profit

-
ELV annual gross profit value is unknown

Gross Margin

-
ELV annual gross profit margin value is unknown

Operating Profit

-
ELV annual operating income value is unknown

Operating Margin

-
ELV annual operating profit margin value is unknown

Net Income

$5.98B
ELV annual net profit is $5.98 billion

Net Margin

3.38%
ELV annual net profit margin is 3.38%

Expenses

Total Expenses

$168.91B
ELV annual total expenses is $168.91 billion

Operating Expenses

$40.56B
ELV annual total operating expenses is $40.56 billion

Cost Of Goods Sold

-
ELV annual cost of goods sold value is unknown

Selling, General & Administrative Expenses

-
ELV annual SGA value is unknown

Depreciation And Amortization

$1.39B
ELV annual depreciation & amortization is $1.39 billion

Interest Expense

$1.19B
ELV annual interest expense is $1.19 billion

Income Tax

$1.93B
ELV annual income tax is $1.93 billion

EBIT & EBITDA

EBIT

$9.09B
ELV annual earnings before interest & taxes is $9.09 billion

EBITDA

$10.48B
ELV annual EBITDA is $10.48 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$116.89B
ELV annual total assets is $116.89 billion

Non Current Assets

$79.29B
ELV annual long term assets is $79.29 billion

Current Assets

$52.56B
ELV annual total current assets is $52.56 billion

Cash And Cash Equivalents

$8.29B
ELV annual cash & cash equivalents is $8.29 billion

Accounts Receivable

$8.01B
ELV annual accounts receivable is $8.01 billion

Inventory

-
ELV annual inventory value is unknown

Liabilities

Total Liabilities

$75.46B
ELV annual total liabilities is $75.46 billion

Long Term Liabilities

$29.22B
ELV annual total long term liabilities is $29.22 billion

Current Liabilities

$26.20B
ELV annual total current liabilities is $26.20 billion

Accounts Payable

$22.67B
ELV annual accounts payable is $22.67 billion

Debt

Total Debt

$31.23B
ELV annual total debt is $31.23 billion

Total Debt 1-year Change

+24.33%
ELV annual total debt is up +24.33% year-on-year

Long Term Debt

$29.22B
ELV annual long term debt is $29.22 billion

Short Term Debt

$2.01B
ELV annual short term debt is $2.01 billion

Equity & Capital

Shareholders Equity

$41.31B
ELV annual stockholders equity is $41.31 billion

Book Value

$41.31B
ELV annual book value is $41.31 billion

Retained Earnings

$33.55B
ELV annual retained earnings is $33.55 billion

Working Capital

$26.36B
ELV annual working capital is $26.36 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$5.81B
ELV annual cash flow from operations is $5.81 billion

Cash From Operations 1-year Change

-27.95%
ELV annual cash flow from operations is down -27.95% year-on-year

Cash From Investing

-$5.17B
ELV annual cash flow from investing activities is -$5.17 billion

Cash From Investing 1-year Change

+7.27%
ELV annual cash flow from investing activities is up +7.27% year-on-year

Cash From Financing

$1.19B
ELV annual cash flow from financing activities is $1.19 billion

Cash From Financing 1-year Change

+135.62%
ELV annual cash flow from financing activities is up +135.62% year-on-year

CAPEX

CAPEX

$1.26B
ELV annual capital expenditures is $1.26 billion

CAPEX 1-year Change

-3.09%
ELV annual capital expenditures is down -3.09% year-on-year

Free Cash Flow

Free Cash Flow

$4.55B
ELV annual free cash flow is $4.55 billion

Free Cash Flow 1-year Change

-32.71%
ELV annual free cash flow is down -32.71% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

-
ELV annual gross profit margin value is unknown

Operating Margin

-
ELV annual operating profit margin value is unknown

Net Margin

3.38%
ELV annual net profit margin is 3.38%

ROA & ROE

ROA

5.30%
ELV annual return on assets is 5.30%

ROE

14.80%
ELV annual return on equity is 14.80%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

16.89
ELV price to earnings ratio is 16.89

PE Ratio Sector Rank

27.18%
ELV price to earnings ratio is higher than 27.18% of companies in Healthcare sector

PB Ratio

PB Ratio

2.38
ELV price to book ratio is 2.38

PB Ratio Sector Rank

66.5%
ELV price to book ratio is higher than 66.5% of companies in Healthcare sector

PS Ratio

PS Ratio

0.56
ELV price to sales ratio is 0.56

PS Ratio Sector Rank

17.21%
ELV price to sales ratio is higher than 17.21% of companies in Healthcare sector

Enterprise value

Enterprise Value

$121.27B
ELV enterprise value is $121.27 billion

Enterprise Value Sector Rank

98.26%
ELV enterprise value is higher than 98.26% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

11.57
ELV EV/EBITDA is 11.57

EV/EBITDA Sector Rank

83.45%
ELV EV/EBITDA is higher than 83.45% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

2.01
ELV annual current ratio is 2.01

Quick Ratio

-
ELV annual quick ratio value is unknown

Leverage

Debt To Equity

0.76
ELV annual debt to equity ratio is 0.76

Interest Coverage Ratio

7.67
ELV annual interest coverage ratio is 7.67

Risk & Stability

Piotroski F-Score

-
ELV piotroski f-score value is unknown

Altman Z-Score

3.22
ELV altman z-score is 3.22

Analyst ratings

Recent major analysts updates

Jan 29, 25 Argus Research
Hold
Jan 28, 25 Wells Fargo
Overweight
Jan 24, 25 Cantor Fitzgerald
Overweight
Jan 24, 25 Barclays
Overweight
Jan 6, 25 Truist Securities
Buy
Nov 5, 24 Mizuho
Outperform
Nov 4, 24 Wells Fargo
Overweight
Oct 23, 24 Morgan Stanley
Overweight
Oct 22, 24 Barclays
Overweight
Oct 21, 24 TD Cowen
Buy

Institutional Ownership

Similar stocks

CI logo
Cigna (CI)
CVS logo
CVS Health (CVS)
MCK logo
McKesson (MCK)
HCA logo
HCA Healthcare (HCA)
MDT logo
Medtronic (MDT)
GSK logo
GSK (GSK)
BMY logo
Bristol-Myers Squibb (BMY)
VRTX logo
Vertex Pharmaceuticals Incorporated (VRTX)
ZTS logo
Zoetis (ZTS)
  • What is the ticker symbol for Elevance Health?
  • Does Elevance Health pay dividends?
  • What sector is Elevance Health in?
  • What industry is Elevance Health in?
  • What country is Elevance Health based in?
  • When did Elevance Health go public?
  • Is Elevance Health in the S&P 500?
  • Is Elevance Health in the NASDAQ 100?
  • Is Elevance Health in the Dow Jones?
  • When was Elevance Health's last earnings report?
  • When does Elevance Health report earnings?
  • Should I buy Elevance Health stock now?

What is the ticker symbol for Elevance Health?

The ticker symbol for Elevance Health is NYSE:ELV

Does Elevance Health pay dividends?

Yes, Elevance Health pays dividends. The last payment was $1.71, with an ex-dividend date on March 10, 2025

What sector is Elevance Health in?

Elevance Health is in the Healthcare sector

What industry is Elevance Health in?

Elevance Health is in the Healthcare Plans industry

What country is Elevance Health based in?

Elevance Health is headquartered in United States

When did Elevance Health go public?

Elevance Health's initial public offering (IPO) was on October 30, 2001

Is Elevance Health in the S&P 500?

Yes, Elevance Health is included in the S&P 500 index

Is Elevance Health in the NASDAQ 100?

No, Elevance Health is not included in the NASDAQ 100 index

Is Elevance Health in the Dow Jones?

No, Elevance Health is not included in the Dow Jones index

When was Elevance Health's last earnings report?

Elevance Health's most recent earnings report was on Jan 23, 2025

When does Elevance Health report earnings?

The next expected earnings date for Elevance Health is Apr 18, 2025

Should I buy Elevance Health stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page